Comparing encounter-based and annualized chronic pseudomonas infection definitions in cystic fibrosis.


Journal

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
ISSN: 1873-5010
Titre abrégé: J Cyst Fibros
Pays: Netherlands
ID NLM: 101128966

Informations de publication

Date de publication:
01 2022
Historique:
received: 01 03 2021
revised: 07 07 2021
accepted: 28 07 2021
pubmed: 17 8 2021
medline: 3 3 2022
entrez: 16 8 2021
Statut: ppublish

Résumé

Chronic Pseudomonas aeruginosa (Pa) infection is associated with increased morbidity and mortality in people with cystic fibrosis (CF). There is no gold standard definition of chronic Pa infection in CF. We compared chronic Pa definitions using encounter-based versus annualized data in the Early Pseudomonas Infection Control (EPIC) Observational study cohort, and subsequently compared annualized chronic Pa definitions across a range of U.S. cohorts spanning decades of CF care. We found that an annualized chronic Pa definition requiring at least 1 Pa+ culture in 3 of 4 consecutive years ("Green 3/4") resulted in chronic Pa metrics similar to established encounter-based modified Leeds criteria definitions, including a similar age at and proportion who fulfilled chronic Pa criteria, and a similar proportion with sustained Pa infection after meeting the chronic Pa definition. The Green 3/4 chronic Pa definition will be valuable for longitudinal analyses in cohorts with limited culture frequency.

Identifiants

pubmed: 34393091
pii: S1569-1993(21)01339-4
doi: 10.1016/j.jcf.2021.07.020
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-44

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Conflict of interest statement All authors confirm that they have no conflicts of interest relevant to this work

Auteurs

Margaret Rosenfeld (M)

Department of Pediatrics, University of Washington, Seattle, WA 98195, USA. Electronic address: Margaret.rosenfeld@seattlechildrens.org.

Anna V Faino (AV)

Children's Core for Biostatistics, Epidemiology and Analytics in Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Frankline Onchiri (F)

Children's Core for Biostatistics, Epidemiology and Analytics in Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Melis A Aksit (MA)

Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD 21287, USA.

Scott M Blackman (SM)

Division of Pediatric Endocrinology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Elizabeth E Blue (EE)

Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA 98195, USA.

Joseph M Collaco (JM)

Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

William W Gordon (WW)

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.

Rhonda G Pace (RG)

Marsico Lung Institute/Cystic Fibrosis Research Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Karen S Raraigh (KS)

Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD 21287, USA.

Yi-Hui Zhou (YH)

Bioinformatics Research Center and Department of Statistics, North Carolina State University, Raleigh, NC 27695, USA; Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695, USA.

Garry R Cutting (GR)

Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD 21287, USA.

Michael R Knowles (MR)

Marsico Lung Institute/Cystic Fibrosis Research Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Michael J Bamshad (MJ)

Department of Pediatrics, University of Washington, Seattle, WA 98195, USA; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Division of Genetic Medicine, Seattle Children's Hospital, Seattle, WA 98105, USA.

Ronald L Gibson (RL)

Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH